HLA-Cw6 and psoriasis

Area of Science:

• Immunogenetics
• Dermatology
• Genetic Epidemiology

Background:

• Psoriasis is a complex, multifactorial skin disease with a significant genetic component.
• The human leukocyte antigen (HLA) HLA-Cw6 allele is a major genetic risk factor for psoriasis.
• The specific roles and clinical implications of HLA-Cw6 in psoriasis pathogenesis and progression require comprehensive review.

Purpose of the Study:

• To systematically review and synthesize the existing knowledge on the association between HLA-Cw6 and psoriasis.
• To explore the influence of HLA-Cw6 on psoriasis phenotype, disease severity, comorbidities, and treatment outcomes.
• To highlight ethnic variations in HLA-Cw6 frequency and its clinical relevance.

Main Methods:

• Literature review of studies investigating the association between HLA-Cw6 and psoriasis.
• Analysis of data concerning disease course, phenotypic characteristics, and treatment responses in HLA-Cw6-positive individuals.
• Examination of epidemiological data on HLA-Cw6 allele frequency across different ethnic groups.

Main Results:

• HLA-Cw6 is strongly associated with early-onset (Type I) psoriasis, particularly guttate forms.
• Patients with HLA-Cw6 often exhibit increased likelihood of trunk, limb, and Koebner phenomenon involvement.
• HLA-Cw6 positivity correlates with better response to methotrexate and ustekinumab, though efficacy differences can be moderate.

Conclusions:

• HLA-Cw6 is a significant genetic marker influencing psoriasis susceptibility, clinical presentation, and therapeutic response.
• The allele's frequency and impact vary across ethnic populations, necessitating tailored research.
• Further studies are crucial to fully elucidate the multifaceted role of HLA-Cw6 in diverse psoriasis patient groups.